DANIEL GLATT: Open Payments
NPI 1649228917 · BURLINGAME, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,753 in 70 payments from 23 companies in 2025. Trend: 2023 $4,580 · 2024 $1,840 · 2025 $2,753
Food & beverage: $1,881Travel & lodging: $872
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 6 | $1,156 |
| ABBVIE INC. | 7 | $159 |
| Lilly USA, LLC | 7 | $154 |
| PFIZER INC. | 7 | $152 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $108 |
| Collegium Pharmaceutical, Inc. | 5 | $104 |
| Novo Nordisk Inc | 4 | $97 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $95 |
| Tonix Medicines, Inc. | 1 | $84 |
| AstraZeneca Pharmaceuticals LP | 3 | $83 |
Products named: SUBLOCADE, JARDIANCE, NURTEC ODT, Belbuca, JOURNAVX, VRAYLAR, NEXLETOL, TRINTELLIX.
Industry payments across CA — which companies pay providers there.
